When to suspect hereditary kidney cancer — young age, both kidneys, a family pattern

It is the pattern, not any single fact, that raises the question. A specialist starts thinking about an inherited cause when kidney cancer is diagnosed at a notably young age, when there is more than one separate tumour or tumours in both kidneys, when more than one close relative on the same side of the family has had kidney cancer, or when the pathology report names an uncommon tumour type. Findings outside the kidney matter too, such as growths in the eye or nervous system, distinctive skin lumps, lung cysts, or fibroids at a young age. One tumour, in one kidney, later in life, with no family history is the common and reassuring picture.

No. Kidney cancer becomes far more common with each decade from middle age onwards, so a diagnosis well before that is unusual enough to be worth a second look, but plenty of younger people have ordinary sporadic kidney cancer with nothing inherited behind it. Age on its own is a reason to ask the question properly rather than an answer to it. What a specialist does is put the age alongside the rest of the picture: how many tumours there are, whether both kidneys are involved, what the pathology says, and who else in the family has been affected. Those things together decide whether genetic evaluation is offered.

Not automatically, but it is the single finding that most often prompts the question. Sporadic kidney cancer is usually one tumour in one kidney. Tumours on both sides, or several separate tumours in the same kidney, suggest that every kidney cell may have started life with the same disadvantage rather than one cell going wrong by chance. There are other explanations, including cancer that has spread from elsewhere and some benign tumours that are naturally multiple, so the scans and the pathology are read together before anything is called inherited. If this is your situation, read our page on bilateral and multifocal kidney tumours.

One close relative diagnosed in later life, with a single tumour and nothing else unusual, does not usually put you into a genetic testing pathway. What raises the question is more than one affected close relative on the same side of the family, a relative diagnosed young, a relative with tumours in both kidneys, or a known inherited condition already in the family. Before any test there is a conversation: the family history is drawn out properly and the relatives' pathology is checked where it can be obtained. People often remember that someone had cancer without remembering which organ, and that one detail can change the whole assessment.

Several are recognised, and they are not interchangeable. Von Hippel-Lindau disease is the one most people have heard of; it involves growths in the eye, the nervous system, the adrenal glands and the pancreas as well as clear cell kidney tumours. Birt-Hogg-Dube syndrome brings skin lumps and lung cysts. Hereditary leiomyomatosis and renal cell cancer brings skin and uterine fibroids at a young age. Hereditary papillary renal cell carcinoma keeps to the kidney and produces multiple papillary tumours. Tuberous sclerosis complex affects the skin, brain and kidneys. Each has a different gene, a different tumour type and a different monitoring plan, which is why naming the right one matters.

NCCN guidance recommends genetic risk evaluation for people with kidney cancer diagnosed at a young age, with more than one tumour or tumours in both kidneys, or with affected close relatives. Meeting the criteria means a referral for genetic counselling, not an immediate blood test. Counselling is led in house by medical oncology at CION: the family history and the pathology are gone through first, what a positive, negative or uncertain result would mean is explained, and a germline test is offered only where the answer would change what happens next. If a syndrome is confirmed, you and your at risk relatives move onto a planned monitoring schedule rather than waiting for symptoms.